Cargando…
Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation
BACKGROUND: The use of HbA1c ≥6.5% for diagnosis of diabetes has been challenged for post-transplantation diabetes mellitus (PTDM) also known as new onset diabetes after transplantation (NODAT) due to a low sensitivity early after renal transplantation. PTDM diagnosed with an oral glucose tolerance...
Autores principales: | Ussif, Amin M., Åsberg, Anders, Halden, Thea Anine Strøm, Nordheim, Espen, Hartmann, Anders, Jenssen, Trond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327477/ https://www.ncbi.nlm.nih.gov/pubmed/30630438 http://dx.doi.org/10.1186/s12882-018-1171-3 |
Ejemplares similares
-
Endothelial Dysfunction and 6-Year Risk of Mortality in Kidney Transplant Recipients
por: Langberg, Nina Elisabeth, et al.
Publicado: (2021) -
Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients
por: Loftheim, Håvard, et al.
Publicado: (2012) -
Patient selection for islet or solid organ pancreas transplantation: experiences from a multidisciplinary outpatient-clinic approach
por: Nordheim, Espen, et al.
Publicado: (2021) -
Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score
por: Ussif, Amin, et al.
Publicado: (2018) -
Marine n-3 Polyunsaturated Fatty Acids and Bone Mineral Density in Kidney Transplant Recipients: A Randomized, Placebo-Controlled Trial
por: Jørgensen, Hanne Skou, et al.
Publicado: (2021)